 Propranolol
"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
| Descriptor ID |
D011433
|
| MeSH Number(s) |
D02.033.100.624.698.711 D02.033.100.624.836 D02.033.755.624.698.711 D02.033.755.624.836 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propranolol".
Below are MeSH descriptors whose meaning is more specific than "Propranolol".
This graph shows the total number of publications written about "Propranolol" by people in UAMS Profiles by year, and whether "Propranolol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2020 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2017 | 3 | 0 | 3 | | 2015 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2013 | 1 | 1 | 2 | | 2012 | 2 | 1 | 3 | | 2010 | 1 | 0 | 1 | | 2009 | 2 | 1 | 3 | | 2008 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2003 | 2 | 0 | 2 | | 2002 | 1 | 0 | 1 | | 2000 | 0 | 3 | 3 | | 1998 | 0 | 1 | 1 | | 1994 | 0 | 2 | 2 | | 1993 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Propranolol" by people in Profiles over the past ten years.
-
Ezeh UC, Ben-Dov T, Taufique ZM, Gaffey MM, Blei F, April MM. A New Approach for Diagnosis and Surveillance of Infantile Subglottic Hemangioma in the Era of Propranolol Use: A Case Series. Ann Otol Rhinol Laryngol. 2024 Feb; 133(2):145-151.
-
Zhang H, Wei T, Johnson A, Sun R, Richter G, Strub GM. NOTCH pathway activation in infantile hemangiomas. J Vasc Surg Venous Lymphat Disord. 2021 03; 9(2):489-496.
-
Gomez-Acevedo H, Dai Y, Strub G, Shawber C, Wu JK, Richter GT. Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration. Sci Rep. 2020 02 24; 10(1):3261.
-
Chao T, Porter C, Herndon DN, Siopi A, Ideker H, Mlcak RP, Sidossis LS, Suman OE. Propranolol and Oxandrolone Therapy Accelerated Muscle Recovery in Burned Children. Med Sci Sports Exerc. 2018 03; 50(3):427-435.
-
Dornhoffer JR, Wei T, Zhang H, Miller E, A Cleves M, Richter GT. The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment. Pediatr Res. 2017 07; 82(1):155-163.
-
Phillips JD, Zhang H, Wei T, Richter GT. Expression of ?-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas. JAMA Facial Plast Surg. 2017 Mar 01; 19(2):102-107.
-
Bolin EH, Lang SM, Tang X, Collins RT. Propranolol Versus Digoxin in the Neonate for Supraventricular Tachycardia (from the Pediatric Health Information System). Am J Cardiol. 2017 05 15; 119(10):1605-1610.
-
Elluru RG, Friess MR, Richter GT, Grimmer JF, Darrow DH, Shin JJ, Perkins JA. Multicenter Evaluation of the Effectiveness of Systemic Propranolol in the Treatment of Airway Hemangiomas. Otolaryngol Head Neck Surg. 2015 Sep; 153(3):452-60.
-
Hoff SR, Rastatter JC, Richter GT. Head and neck vascular lesions. Otolaryngol Clin North Am. 2015 Feb; 48(1):29-45.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|